ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Vietti Heads Chairman’s Committee; Chabner Seeks Deputy Candidates; WHO Centers At MSK

December 2, 1988

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992

Tobacco Use Research Centers Funded

October 22, 1999

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

September 9, 2005

In Brief: John Campbell, Nida Contracts Chief, New Head Of NCI Contracts Branch; PHS Honors Seven At NCI

June 10, 1983

Research Base Would Be Increased In Guideline Change

November 9, 1990